Chairs of the House Energy & Commerce Committee and its health subcommittee said Wednesday (Jan. 16) they will hold hearings on drug-pricing issues, including insulin prices and patent gaming. The statements by full committee Chair Frank Pallone (D-NJ) and oversight and investigations subcommittee Chair Diana DeGette (D-CO) come less than a week after their Democratic colleague, House Oversight and Reform Committee Chair Rep. Elijah Cummings (MD), announced the first in a series of hearings to investigate prescription drug pricing later...